The Society of NeuroInterventional Surgery (SNIS) has announced that William Mack (Los Angeles, USA) has become the new president of the organisation. The announcement was made during the society’s’ 17th annual meeting (4–7 August), which was held virtually.
The change makes Richard Klucznik (Houston, USA) the SNIS immediate past president and means Mack will lead the SNIS’s initiatives to advance excellence in minimally invasive neuroendovascular care.
“The field of neurointervention is flourishing, driven by the brightest minds who continue to adapt and innovate to meet the challenges of a rapidly changing world,” said Mack in the society’s announcement. “I look forward to both the challenges and opportunities to come in the year ahead and promise to drive forward SNIS’s mission of championing patients and improvements to systems that will help them receive timely and appropriate care.”
The SNIS noted that in addition to his clinical work at the University of Southern California, Mack is the principal investigator and director of the cerebrovascular laboratory in the Zilkha Neurogenetic Institute.
His scientific interests focus on translational efforts to treat ischaemic and haemorrhagic stroke, and his laboratory investigations concentrate on the pathophysiology of stroke and inflammatory modulation.
Using the information and experience gained in the laboratory, Mack is working to develop new technologies, techniques, and therapies to directly improve the clinical care administered to stroke patients.
The president-elect of SNIS is Michael Chen (Chicago, USA) and J Mocco (New York, USA) has been elected vice president.